Olaparib and Cediranib Maleate in Treating Patients With Recurrent, Refractory, or Metastatic Endometrial Cancer
about
Olaparib and Cediranib Maleate in Treating Patients With Recurrent, Refractory, or Metastatic Endometrial Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Olaparib and Cediranib Maleate ...... Metastatic Endometrial Cancer
@en
type
label
Olaparib and Cediranib Maleate ...... Metastatic Endometrial Cancer
@en
prefLabel
Olaparib and Cediranib Maleate ...... Metastatic Endometrial Cancer
@en
P4844
P6153
P1476
A Randomized Phase II Study Co ...... Metastatic Endometrial Cancer
@en
P3098
NCT03660826
P580
2019-04-08T00:00:00Z
P582
2020-09-04T00:00:00Z